RBJ, also known as RING finger and B-box domain-containing protein 1 (RBBP1), is a multifunctional protein involved in various cellular processes, including chromatin remodeling, transcriptional regulation, DNA repair, and cell cycle progression. It contains several functional domains, including a RING finger domain and a B-box domain, which are characteristic of E3 ubiquitin ligases involved in protein ubiquitination and degradation. Additionally, RBJ interacts with numerous other proteins, serving as a scaffold for the assembly of multiprotein complexes involved in chromatin remodeling and transcriptional regulation. One of its well-known functions is its role as a core component of the histone deacetylase (HDAC) complex, where it helps to recruit histone deacetylases to target genes, leading to chromatin condensation and transcriptional repression.
Inhibition of RBJ can occur through various mechanisms, primarily targeting its ubiquitin ligase activity or its protein-protein interactions. One approach to inhibit RBJ is to disrupt its E3 ubiquitin ligase activity, preventing the ubiquitination and subsequent degradation of target proteins involved in cellular processes such as cell cycle regulation or DNA repair. This can be achieved through the development of small molecule inhibitors or peptides that specifically block the catalytic activity of the RING finger domain. Another strategy is to disrupt the protein-protein interactions mediated by RBJ, thereby preventing its recruitment to specific target genes or protein complexes. This can be accomplished by designing molecules that interfere with the binding interfaces between RBJ and its interacting partners, disrupting the assembly of multiprotein complexes essential for chromatin remodeling and transcriptional regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Specific inhibitor of PKC, it could suppress RBJ by attenuating PKC-mediated phosphorylation events integral to RBJ functionality. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
By chelating intracellular calcium, it might reduce calcium-dependent activations that RBJ relies on. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
SERCA inhibition can lead to altered calcium dynamics, potentially disrupting pathways that modulate RBJ activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
By increasing intracellular calcium, it might induce calcium overloads, hindering calcium-sensitive processes involving RBJ. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Interfering with CaMKII could impact downstream targets of RBJ through calcium-related pathways. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
As a PKC inhibitor, it may alter cellular processes that RBJ is involved in by reducing PKC-mediated signals. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $33.00 $64.00 | 11 | |
Inhibition of NF-kB could disrupt transcriptional regulation of genes in pathways where RBJ is active. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Affecting multiple PKC isoforms might inhibit pathways or processes where RBJ acts in conjunction with PKC. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Blocking calmodulin might disrupt interactions or pathways that rely on calcium/calmodulin binding and which RBJ is a part of. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibiting MLCK may alter cell motility processes in which RBJ plays a role, possibly through cytoskeletal modifications. | ||||||